ArticleArchives of public health = Archives belges de sante publique2016
Accounting for multimorbidity can affect the estimation of the Burden of Disease: a comparison of approaches.
Article in Archives of public health = Archives belges de sante publique, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices.European journal of public health · 2022Pooled it
- The burden of brain disorders in Norway: an analysis of data from the global burden of disease study 2023.The Lancet regional health. Europe · 2026Article
- Pre-pandemic sub-national disparities in the disease burden of ischemic heart disease and stroke in France.BMC cardiovascular disorders · 2026Article
- Sub-national disparities in disease burden of diabetes mellitus and chronic kidney disease in France: a pre-pandemic analysis.Archives of public health = Archives belges de sante publique · 2025Article
- Economic burden of Sanfilippo syndrome in the United States.Archives of public health = Archives belges de sante publique · 2025Article
- Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data.Population health metrics · 2025Article
- Economic Evaluation of Oral Ivermectin, Alone or in Combination with Permethrin, versus Permethrin, in the Treatment of Classic Scabies in the Philippine Setting.Acta medica Philippina · 2025Article
- Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study.Journal of medical Internet research · 2024Article
- A novel comorbidity index in Italy based on diseases detected by the surveillance system PASSI and the Global Burden of Diseases disability weights.Population health metrics · 2023Article
- Multimorbidity Patterns in the Urban Population in Poland.Journal of clinical medicine · 2023Article
- The health and economic burden of musculoskeletal disorders in Belgium from 2013 to 2018.Population health metrics · 2023Article
- Model-based estimation of burden of COVID-19 with disability-adjusted life years and value of statistical life in West Bengal, India.BMJ open · 2023Article
- The Burden of Disease in Germany at the National and Regional Level—Results in Terms of Disability-Adjusted Life Years (DALY) from the BURDEN 2020 Study.Deutsches Arzteblatt international · 2022Article
- TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi.BMJ global health · 2022Article
- Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020.Archives of public health = Archives belges de sante publique · 2022Article
- Adjustment for Multimorbidity in Estimations of the Burden of Diseases Using Korean NHIS Data.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022Article
- Multimorbidity adjusted years lost to disability rates calculated through Monte-Carlo simulation in Korea.Epidemiology and health · 2022Article
- Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada.PLOS global public health · 2022Article
- Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.PLOS global public health · 2022Article
- Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year.BMC public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVarious Burden of Disease (BoD) studies do not account for multimorbidity in their BoD estimates. Ignoring multimorbidity can lead to inaccuracies in BoD estimations, particularly in ageing populations that include large proportions of persons with two or more health conditions. The objective of this study is to improve BoD estimates for the Netherlands by accounting for multimorbidity. For this purpose, we analyzed different methods for 1) estimating the prevalence of multimorbidity and 2) deriving Disability Weights (DWs) for multimorbidity by using existing data on single health conditions.
methodsWe included 25 health conditions from the Dutch Burden of Disease study that have a high rate of prevalence and that make a large contribution to the total number of Years Lived with a Disability (YLD). First, we analyzed four methods for estimating the prevalence of multimorbid conditions (i.e. independent, independent age- and sex-specific, dependent, and dependent sex- and age-specific). Secondly, we analyzed three methods for calculating the Combined Disability Weights (CDWs) associated with multimorbid conditions (i.e. additive, multiplicative and maximum limit). A combination of these two approaches was used to recalculate the number of YLDs, which is a component of the Disability-Adjusted Life Years (DALY).
resultsThis study shows that the YLD estimates for 25 health conditions calculated using the multiplicative method for Combined Disability Weights are 5 % lower, and 14 % lower when using the maximum limit method, than when calculated using the additive method. Adjusting for sex- and age-specific dependent co-occurrence of health conditions reduces the number of YLDs by 10 % for the multiplicative method and by 26 % for the maximum limit method. The adjustment is higher for health conditions with a higher prevalence in old age, like heart failure (up to 43 %) and coronary heart diseases (up to 33 %). Health conditions with a high prevalence in middle age, such as anxiety disorders, have a moderate adjustment (up to 13 %).
conclusionsWe conclude that BoD calculations that do not account for multimorbidity can result in an overestimation of the actual BoD. This may affect public health policy strategies that focus on single health conditions if the underlying cost-effectiveness analysis overestimates the intended effects. The methodology used in this study could be further refined to provide greater insight into co-occurrence and the possible consequences of multimorbid conditions in terms of disability for particular combinations of health conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.